1. Home
  2. XENE vs MCY Comparison

XENE vs MCY Comparison

Compare XENE & MCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • MCY
  • Stock Information
  • Founded
  • XENE 1996
  • MCY 1961
  • Country
  • XENE Canada
  • MCY United States
  • Employees
  • XENE N/A
  • MCY N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • MCY Property-Casualty Insurers
  • Sector
  • XENE Health Care
  • MCY Finance
  • Exchange
  • XENE Nasdaq
  • MCY Nasdaq
  • Market Cap
  • XENE 3.3B
  • MCY 3.7B
  • IPO Year
  • XENE 2014
  • MCY N/A
  • Fundamental
  • Price
  • XENE $39.73
  • MCY $52.25
  • Analyst Decision
  • XENE Strong Buy
  • MCY Strong Buy
  • Analyst Count
  • XENE 7
  • MCY 1
  • Target Price
  • XENE $57.00
  • MCY $80.00
  • AVG Volume (30 Days)
  • XENE 440.4K
  • MCY 974.3K
  • Earning Date
  • XENE 02-27-2025
  • MCY 02-11-2025
  • Dividend Yield
  • XENE N/A
  • MCY 2.43%
  • EPS Growth
  • XENE N/A
  • MCY 385.68
  • EPS
  • XENE N/A
  • MCY 8.45
  • Revenue
  • XENE N/A
  • MCY $5,475,633,000.00
  • Revenue This Year
  • XENE N/A
  • MCY N/A
  • Revenue Next Year
  • XENE $1,599.99
  • MCY $7.13
  • P/E Ratio
  • XENE N/A
  • MCY $6.18
  • Revenue Growth
  • XENE N/A
  • MCY 18.27
  • 52 Week Low
  • XENE $35.53
  • MCY $44.19
  • 52 Week High
  • XENE $50.99
  • MCY $80.72
  • Technical
  • Relative Strength Index (RSI)
  • XENE 51.79
  • MCY 46.18
  • Support Level
  • XENE $38.22
  • MCY $50.27
  • Resistance Level
  • XENE $39.73
  • MCY $62.84
  • Average True Range (ATR)
  • XENE 1.21
  • MCY 2.69
  • MACD
  • XENE 0.01
  • MCY 0.74
  • Stochastic Oscillator
  • XENE 68.12
  • MCY 28.01

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

About MCY Mercury General Corporation

Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The Company offers the following types of automobile coverage: collision, property damage, bodily injury ("BI"), comprehensive, personal injury protection ("PIP"), underinsured and uninsured motorist, and other hazards. The Company offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages.

Share on Social Networks: